Mosseri Marlio Charles

Mosseri Marlio Charles, 10% Owner, accounts for 2 disclosed filings worth $1.9M, all concentrated in Nuvectis Pharma, Inc. (NVCT), active 2025–2026. The record is heavily weighted toward buying, with $1.9M in purchases against $0 in sales. The largest single open-market purchase on record is $957.1K in Nuvectis Pharma, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.